Successful antitumor activity of IFN-α has been demonstrated in these studies, and there have been some case reports demonstrating the therapeutic effect of IFN-α on macular edema in diabetic patients and wet type macular degeneration [12,13]. The gene discussed is IFNA1; the disease is macular retinal edema.